American Well (NYSE:AMWL) Insider Dmitry Zamansky Sells 6,243 Shares of Stock

American Well Corporation (NYSE:AMWL) insider Dmitry Zamansky sold 6,243 shares of the business’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $4.85, for a total value of $30,278.55. Following the transaction, the insider directly owned 191,468 shares in the company, valued at $928,619.80. This trade represents a 3.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

American Well Price Performance

Shares of NYSE AMWL opened at $5.21 on Tuesday. The firm has a 50-day moving average of $4.42 and a 200 day moving average of $6.14. The stock has a market cap of $85.35 million, a P/E ratio of -0.72 and a beta of 1.26. American Well Corporation has a 1 year low of $3.71 and a 1 year high of $12.95.

American Well (NYSE:AMWL) last posted its earnings results on Tuesday, November 4th. The company reported ($1.74) EPS for the quarter, topping analysts’ consensus estimates of ($1.83) by $0.09. The business had revenue of $56.29 million during the quarter, compared to analyst estimates of $54.56 million. American Well had a negative return on equity of 39.80% and a negative net margin of 42.80%. Research analysts expect that American Well Corporation will post -9.34 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on AMWL shares. Wells Fargo & Company lowered their target price on American Well from $12.00 to $9.00 and set an “overweight” rating for the company in a research report on Wednesday, November 5th. Weiss Ratings reiterated a “sell (e+)” rating on shares of American Well in a research report on Wednesday, October 8th. Wall Street Zen cut shares of American Well from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Stifel Nicolaus reduced their target price on shares of American Well from $8.00 to $6.00 and set a “hold” rating on the stock in a report on Wednesday, November 5th. Finally, Morgan Stanley lowered their price target on shares of American Well from $10.50 to $6.00 and set an “equal weight” rating for the company in a report on Thursday, December 18th. One analyst has rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $7.58.

Institutional Investors Weigh In On American Well

Hedge funds and other institutional investors have recently made changes to their positions in the company. Headlands Technologies LLC bought a new stake in shares of American Well in the 2nd quarter worth about $39,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in American Well in the 3rd quarter worth about $62,000. Prelude Capital Management LLC bought a new stake in American Well in the third quarter worth about $86,000. Connor Clark & Lunn Investment Management Ltd. bought a new stake in American Well in the second quarter worth about $89,000. Finally, Engineers Gate Manager LP purchased a new position in shares of American Well during the second quarter valued at approximately $101,000. Hedge funds and other institutional investors own 56.05% of the company’s stock.

American Well Company Profile

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company’s core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.